Daphna Levy

1.2k total citations
7 papers, 884 citations indexed

About

Daphna Levy is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Daphna Levy has authored 7 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 2 papers in Genetics. Recurrent topics in Daphna Levy's work include CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (5 papers) and Virus-based gene therapy research (2 papers). Daphna Levy is often cited by papers focused on CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (5 papers) and Virus-based gene therapy research (2 papers). Daphna Levy collaborates with scholars based in Israel, United States and Australia. Daphna Levy's co-authors include Michal J. Besser, Gal Markel, Jacob Schachter, Orit Itzhaki, Ronnie Shapira‐Frommer, Adva Kubi, Avraham J. Treves, Bruria Shalmon, Arnon Nagler and Sara Apter and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Cancer Immunology Immunotherapy.

In The Last Decade

Daphna Levy

7 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daphna Levy Israel	7	774	648	173	164	51	7	884
Chiara Casati Italy	13	563 0.7×	579 0.9×	274 1.6×	147 0.9×	37 0.7×	13	911
Nikolaos Zacharakis United States	5	596 0.8×	478 0.7×	257 1.5×	83 0.5×	56 1.1×	9	771
Laura Bies Netherlands	5	819 1.1×	700 1.1×	293 1.7×	217 1.3×	38 0.7×	8	976
Dov Zippel Israel	9	474 0.6×	368 0.6×	103 0.6×	160 1.0×	41 0.8×	13	628
Stephanie Silveria United States	5	328 0.4×	472 0.7×	223 1.3×	84 0.5×	30 0.6×	6	723
Tamara Laskowski United States	7	395 0.5×	403 0.6×	201 1.2×	76 0.5×	43 0.8×	8	645
Liat Hershkovitz Israel	5	505 0.7×	436 0.7×	146 0.8×	114 0.7×	62 1.2×	5	638
Xuexiang Du United States	10	586 0.8×	504 0.8×	204 1.2×	96 0.6×	74 1.5×	21	856
Weiqing Jing United States	15	452 0.6×	479 0.7×	225 1.3×	63 0.4×	38 0.7×	29	825
Sarah Oelsner Germany	8	651 0.8×	601 0.9×	125 0.7×	99 0.6×	12 0.2×	8	758

Countries citing papers authored by Daphna Levy

Since Specialization

Citations

This map shows the geographic impact of Daphna Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphna Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphna Levy more than expected).

Fields of papers citing papers by Daphna Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daphna Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphna Levy. The network helps show where Daphna Levy may publish in the future.

Co-authorship network of co-authors of Daphna Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Daphna Levy. A scholar is included among the top collaborators of Daphna Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daphna Levy. Daphna Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Besser, Michal J., Ronnie Shapira‐Frommer, Orit Itzhaki, et al.. (2013). Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies. Clinical Cancer Research. 19(17). 4792–4800. 294 indexed citations

2.

Greenberg, Eyal, Michal J. Besser, Eytan Ben‐Ami, et al.. (2013). A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study. Biomarkers. 18(6). 502–508. 39 indexed citations

3.

Sapoznik, Sivan, Rona Ortenberg, Gilli Galore-Haskel, et al.. (2012). CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy. Cancer Immunology Immunotherapy. 61(10). 1833–1847. 39 indexed citations

4.

Levy, Daphna, et al.. (2012). Activation of Cell Cycle Arrest and Apoptosis by the Proto-Oncogene Pim-2. PLoS ONE. 7(4). e34736–e34736. 20 indexed citations

5.

Itzhaki, Orit, Daphna Levy, Dragoslav Zikich, et al.. (2012). Adoptive T-cell Transfer in Melanoma. Immunotherapy. 5(1). 79–90. 16 indexed citations

6.

Itzhaki, Orit, Einat Hovav, Daphna Levy, et al.. (2011). Establishment and Large-scale Expansion of Minimally cultured “Young” Tumor Infiltrating Lymphocytes for Adoptive Transfer Therapy. Journal of Immunotherapy. 34(2). 212–220. 124 indexed citations

7.

Besser, Michal J., Ronnie Shapira‐Frommer, Avraham J. Treves, et al.. (2010). Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients. Clinical Cancer Research. 16(9). 2646–2655. 352 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact